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Abstract 
The purpose of this research was to prepare and characterize a novel lyophilized 
chitosan-based hydrogel complex (termed CS-M) for controlled drug delivery 
applications using a highly water soluble model drug, niacinamide. Characterization 
studies were undertaken to evaluate the physical-chemical properties, polymer swelling, 
in vitro controlled release kinetics, tissue bioadhesion, intestinal permeability and 
stability of the novel chitosan complex. Additionally, a comparative analysis was 
conducted with commercial polymers namely, Carbopol 974P-NF® and hydroxypropyl 
methylcellulose (HPMC K4M). FT–IR and 1H NMR studies confirmed that despite 
alteration in physical structure and morphology of the chitosan complex the chemical 
properties remained unchanged, when compared to the parent chitosan compound.  
Polymer swelling studies showed consistency in the structural integrity and water uptake 
of CS-M compared to other polymers which showed inconsistent swelling and 
disintegration behavior over a 5 h period.  In vitro controlled release profiles of CS-M 
showed a slower, more controlled release rate of niacinamide than other polymers 
indicating the influence of polymer swelling capacity on water uptake and subsequent 
drug release. CS-M demonstrated an overall increase in bioadhesion to intestinal tissue 
when compared to commercial polymers at same concentrations. Similarly, drug 
transport through everted sac intestinal tissue showed enhanced absorption properties of 
CS-M when compared to other polymers. Finally, a 3 month accelerated stability study 
showed all polymers including CS-M to be stable when formulated with niacinamide. 
Overall, the modified chitosan-based hydrogel polymer, CS-M, demonstrated enhanced 
characteristics indicating its potential to be used as a controlled release excipient in oral 
drug formulations. 
Keywords: Chitosan hydrogel complex, controlled drug delivery, niacinamide, 
lyophilization, Carbopol 974P-NF, HPMC K4M 
 
Introduction 
Chitosan, an amino-polysaccharide derived by 
deacetylation from parent compound chitin, is 
abundantly found on the exoskeleton of crabs. In 
recent times, it has been widely applied in the fields 
of drug delivery and tissue engineering because of its 
biodegradability, non-toxicity and good 
biocompatibility (1-4). It is presently approved as a 
food additive in Japan, Italy and Finland (5). 
However, there are some limitations to the use of CS 
such as poor solubility in aqueous medium (at higher 
pH), poor compressibility and erratic flow properties 
that make it difficult to incorporate this polymer in 
preparation of controlled release dosage forms. CS 
does, however, make salts with inorganic and organic 
acids such as hydrochloric acid, acetic acid, glutamic 
acid, and lactic acid. These salts are soluble in water, 
the solubility depending on the degree of 
deacetylation and the pH of solution. To further 
enhance the solubility of this polymer and to improve 
its mucoadhesive and permeation enhancing 
properties, various derivatives such as chitosan 
glutamate, N-trimethyl chitosan chloride and thiolated 
chitosans have been developed (6-8). However, these 
processes require extensive chemical treatment and 
processing steps which in turn lead to increased 
expense and time.  
The objective of our study was to develop a modified 
chitosan hydrogel complex (termed CS-M) designed 
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to overcome these limitations and serve as an ideal 
controlled release agent in oral dosage forms. The 
formation of CS-M polymer was based on a simple 
freeze-dried process that resulted in a compound with 
improved qualities than that of its parent compound, 
chitosan. Additionally, when compared to 
commercially available polymers, the performance of 
the chitosan hydrogel was vastly improved. Studies 
were conducted to characterize the CS-M polymer 
using physical-chemical methods such as Fourier 
transform infrared (FT–IR) and proton nuclear 
magnetic resonance (1H-NMR) spectroscopy. Polymer 
swelling studies were conducted to determine the 
influence of swollen CS-M polymers on the 
controlled release characteristics of niacinamide. The 
swelling behavior was compared with conventional 
rate controlling polymers, hydroxypropyl 
methylcellulose (HPMC K4M) and a carbomer 
(Carbopol 974P-NF®), and correlated with the in 
vitro drug release characteristics of these polymers.  
Intestinal tissue bioadhesion and drug permeability 
were also evaluated to gauge the effects of the 
hydrogel polymer on retention of the dosage form on 
the tissue and its subsequent effect on transport of the 
drug through rat small intestine. Finally, accelerated 
stability studies were conducted to determine 
niacinamide drug degradation upon storage for 
prolonged periods of time in all of the polymer 
formulations.         
 
Materials and methods 
Materials 
Chitosan (CS, 50 K Da, low molecular weight) and 
the model drug, niacinamide, were purchased from 
Sigma-Aldrich (St. Louis, Missouri). Avicel® pH 101 
(microcrystalline cellulose) was provided by FMC 
Biopolymer (Newark, Delaware). Methocel® K4M, 
hydroxypropyl methylcellulose (HPMC K4M) was 
provided by Dow Chemicals (Midland, Michigan), 
Carbopol 974P-NF® was provided by Noveon 
(Cleveland, Ohio). Magnesium stearate and talc was 
purchased from Fisher Scientific (Fairlawn, New 
Jersey). All chemicals and solvents were of analytical 
grade. 
 
Fourier Transform Infrared Spectroscopy (FTIR) 
FTIR spectra of chitosan (CS) and CS-M using a 
Nicolet Magna-IR 560 (Nicolet Instrument 
Technologies, Madison, WI) were recorded. A 1% 
sample of CS and CS-M was mixed in powdered 
potassium bromide and then cold compressed in a 0.5 
in (inside diameter) die under 200 MPa pressure. The 
cold compressed sample-potassium bromide discs 
were transparent and spectra were recorded from 4000 
cm-1 to 400 cm-1 using a 128 scan. 
 
Proton Nuclear Magnetic Resonance (1H-NMR) 
NMR spectra for CS and CS-M were obtained on a 
Varian Gemini 200 MHz broadband (Varian, Palo 
Alto, CA) spectrophotometer. The reference used was 
3-triisopropylsilyl propylsulfonate. 5 mg samples 
were diluted in 0.75 ml of solvent, 1% DCL/D2O and 
study performed at room temperature.  
 
 
Preparation of the modified chitosan hydrogel 
complex formulation (CS-M) 
1g of low molecular weight (50 KDa) chitosan flakes 
was dissolved in a 1% acetic acid solution. 
Subsequently, sodium chloride was added in 1:4 ratio 
into the mixture. The solution was filtered to remove 
any undissolved particles, poured into a vacuum flask, 
sealed and placed into the shell freezer (Labconco, 
Kansas City, Missouri) for 1 h. The frozen sample 
was transferred to a freeze-dry system, Freezone® 4.5 
(Labconco, Kansas City, Missouri), and dried 
overnight (18h). The resulting product was retrieved 
as a free flowing (angle of repose, < 35o), fine white 
powder form of CS-M with excellent compressibility 
as tested using a single punch tablet machine (Carver 
Inc., IN).  
 
Preparation of CS-M polymer-based formulations 
Multiple tablet formulations were prepared as follows: 
Formulations (F1 – F3) contained 20% concentrations 
of each polymer HPMC K4M, Carbopol 974P-NF 
97® and CS-M, respectively, within the formulations 
(Table 1). Niacinamide, a highly water soluble drug, 
was used as a model drug in these formulations. 
Polymer swelling capacity, in vitro dissolution, tissue 
bioadhesion, drug transport and stability studies were 
carried out to assess characteristics of the newly 
developed  CS-M hydrogel polymer. Avicel® pH 101 
(microcrystalline cellulose) was used as a filler and 
magnesium stearate and talc as a lubricant and 
glidant, respectively. After blending the powders, the 
formulations were transferred to a 16-station mini 
tablet rotary press (Riddhi Pharma, India) for direct 
compression. Tablets without polymers were prepared 
as controls. All tablets were enteric coated with 5% 
Eudragit® L–100 to protect the tablet(s) from the 
simulated gastric fluids. The core tablets were 
evaluated for weight variation and hardness. All 
formulations were subject to friability testing on a 
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VanKel friabilator model 45-2000 (Cary, NC) prior to 
continuing with experiments.  
 
Polymer swelling studies 
Swelling studies of tablets provide information of 
water uptake by the polymer and its influence on the 
drug release mechanisms in the G.I. transit system (9).  
Formulations (F1 – F3) were subjected to swelling 
studies in a USP Type 1 (basket) dissolution apparatus 
(Vankel, Cary, NC). Tablets were placed in the basket 
attached to the dissolution apparatus containing 300 
ml of pH 6.8 PBS solution. The water bath was 
maintained at 37 + 0.5 °C and the basket rotating 
speed was maintained at 50 rpm. At designated time 
intervals, the basket was removed and excess water 
was wiped off from the mesh and surrounding area. 
The swollen tablet weight was recorded and the water 
uptake determined by the following equation (9): 
Q = (Ws – Wd)  x 100 
Wd 
where,  
Q   = water uptake (%), Wd = weight of dry tablet and 
Ws = weight of swollen tablet. All swelling studies 
were performed in triplicate.  
 
In vitro drug release studies 
Dissolution studies were conducted using the USP 
Type I (Basket) apparatus for all formulations (F1 – 
F3). The basket speed rotation was maintained at 50 
rpm and the temperature was set at 37 + 0.5 ºC. The 
drug release studies were conducted in 300 ml of 0.1N 
HCl, for two hours, to mimic the gastric environment, 
replaced with 300 ml of phosphate buffered saline 
(PBS) solution at a pH of 6.8 for an additional 5 h. At 
predetermined time intervals, 3 ml samples were 
withdrawn and assayed for drug release 
spectrophotometrically at a wavelength of 262 nm. 
All experiments were conducted in triplicate.  
 
Evaluation of tissue bioadhesion 
The determination of adhesion strength of the 
polymer samples to the rat intestinal tissue was done 
using a Du Nouy surface tensiometer model 20 
apparatus per a previously described method (10). 
Following established animal handling protocols and 
approval from the university animal use committee, 
intestinal tissue was harvested from female Sprague 
Dawley rats (Harlan, San Diego, CA) which were 
anaesthetized for 5 minutes using isofluorane. A foot 
pinch test was performed prior to cervical dislocation 
being carried out. Three tablets from each polymer 
formulation were glued on to a petri-dish. The tablets  
 
were soaked for 5 min in a phosphate buffered saline  
(PBS) medium. A 1.5 cm long segment of rat intestine 
was cut to expose the mucosal side. The tissue was 
mounted on a metal ring (4.8 cm length/1.4 cm 
diameter dimensions) and the mucosal surface was 
allowed to make contact with tablet for a duration of 2 
min. The metal ring was slowly raised until the 
tension caused the tablet surface to detach from the 
tissue. The value was then recorded in dynes/cm2 as 
observed from the dial. 
 
In vitro tissue permeability studies 
The everted sac technique was used to determine drug 
transport across the rat intestine (11). The small 
intestine segment of the rat was rinsed with 0.9% ice-
cold saline and transferred into a beaker filled with 
oxygenated Tyrode buffer, pH 7.4. Tablets 
formulations (F1-F3) were incubated in 10 ml Tyrode 
buffer, in a 16 X 100 mm test tube for 20 minutes, 
which is the optimal time for the tablet to equilibrate 
at the swollen state (12). The small intestine was cut 
into 6 cm segments, everted on a glass rod and tied at 
one end with a suture thread. The suture was then tied 
to a small washer and the open end of the intestine 
was fitted over the tip of a glass pipette with open 
ends. The open end of the glass pipette was pushed 
into one of the three openings of a rubber stopper. The 
intestine was then placed into the test tube containing 
the tablet. The rubber stopper was secured in an 
Erlenmeyer flask with 200 ml of water and placed 
into a moving water bath model 4682 (Lab-Line, 
Melrose Park, Illinois) at 37 + 0.5 °C with a speed of 
50 rpm. 1.0 ml of Tyrode buffer was added to the 
everted intestinal sac and 0.5 ml samples were 
withdrawn into vials. Samples were taken at 
designated time intervals and analyzed on the HPLC. 
All everted sac studies were performed in triplicate. 
Samples of niacinamide collected from the mucosal 
Table 1: Formulation chart for niacinamide tablet 
formulations containing different polymers  
    
Ingredients (%) F1 F2 F3 
Avicel pH 101 57.57 57.57 57.57 
HPMC K4M 20 - - 
Carbopol 974P-NF - 20 - 
CS-M - - 20 
Talc  0.5 0.5 0.5 
Magnesium Stearate 0.5 0.5 0.5 
Niacinamide active  21.43 21.43 21.43 
        
Total (%) 100 100 100 
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side of the intestinal everted sacs were analyzed on an 
HP Series 1100. A Prodigy 5μ, ODS3 100 Å, 250mm 
x 4.60 mm column was used to analyze the drug. The 
temperature was maintained at 25ºC and samples were 
measured at 262 nm. The mobile phase consisted of 
10 mM KH2PO4 and methanol (40:60). The flow rate 
was set at 1 ml/min. The injection volume was 20 μl 
and the relative retention time was 4 minutes.  
 
0.0
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Stability studies 
All formulations were subjected to accelerated 
stability testing, by placing each of the tablet 
formulations in the stability chamber, model 9005 
(VWR, Cornelius, Oregon) maintained at 40 ºC with a 
relative humidity of 75%. Samples were taken out at 
one, two and three month intervals and dissolution 
testing was performed on these samples. The samples 
were analyzed at a wavelength of 262 nm using a UV-
Vis spectrophotometer (Shimadzu, CA). 
14001900 2400 290034003900
 
Results and discussion 
Characterization of CS-M: FTIR and 1H-NMR 
spectroscopy 
The FT-IR spectra of the investigated polymer are 
represented in Figure 1. Figure 1 (a) shows the 
absorption peaks of CS-M, whereas, Figure 1 (b) and 
1 (c) show the absorption peaks of sodium chloride 
and untreated chitosan, respectively. Modified 
chitosan (CS-M) (Figure 1a) showed a characteristic 
absorption band at 3420 cm-1 attributed to the 
stretching vibration of the amide (N-H) and the 
hydroxyl (O-H) groups whereas the width of the band 
indicated that the hydrogen bonding was enhanced 
(13-14).  The bands at 1600 and 1260 cm-1 show the 
bending vibrations of the N-H and the O-H groups, 
respectively. In Figure 1c, the absorbance spectrum at 
3420 cm-1 was much more muted than that of the CS-
M. However, the absorbance peaks for both 
compounds were at similar wavelength numbers 
indicating that there was no difference in the structure 
of the two compounds. The peaks ranging from 1640-
1740 cm-1 represented the carbonyl (C=O) functional 
group. This functional group was more dominant in 
CS-M than that of parent chitosan indicating that there 
was more acetylation in the CS-M structure.  
Overall, the objective of FTIR study was to identify 
the functional groups that exist within both the 
polymers. From observations of the FTIR spectrum, 
the chemical structure of CS-M was unaltered from 
that of the parent compound indicating that the 
modified version retained all the chemical properties 
of the parent compound, chitosan (CS).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figures 2(a) and 2(b) represent the 1H NMR spectra  
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Figure 1. Fourier Transform Infrared (FTIR) data for (a) chitosan 
hydrogel salt complex (CS-M) (b) sodium chloride, and (c) parent 
compound, chitosan (CS).  
 
 
 
 
 
 
 (b) 
(a) 
Figure 2.Proton nuclear magnetic resonance (1H-NMR) data for 
(a) chitosan (CS) and (b) chitosan hydrogel salt complex (CS-M). 
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Figures 2(a) and 2(b) represent the 1H NMR 
spectra of CS and CS-M, respectively. The CS 
spectra demonstrated a decrease in acetyl group at 
2.097ppm compared to the CS-M spectrum (Figure 
2b). Other than the sharp distinction of the acetyl 
group, CS and CS-M spectra were quite similar. The 
presence of an increased number of acetyl groups in 
CS-M was further confirmed after the FTIR analysis 
indicated the same trend. Thus, this study also verified 
that there was no change in the chemical structure of 
CS-M when compared to CS. 
 
In vitro polymer swelling studies 
Figure 3 compared the amount of water uptake and 
the resultant swelling effect from formulations (F1, F2 
and F3), i.e., 20% HPMC K4M, 20% Carbopol 974P-
NF® and 20% CS-M polymer formulations, 
respectively. As represented in Figure 3, for 
formulation (F3) containing 20% CS-M, the amount 
of water uptake reached equilibrium within one hour 
of the run whereby swelling increased by ~276%. 
After 5 h, water uptake only increased to 304%, 
however the shape and integrity of the tablet was 
maintained throughout the duration of the study. With 
formulation (F1) containing 20% HPMC K4M 
hydration occurred during the first hour with 375% 
increase in swelling but slowly diminished over the 
five hour study indicating a slow erosion process. 
HPMC K4M polymer is known to quickly hydrate as 
demonstrated in the literature (15), this effect was 
confirmed in our study. Formulation (F2) containing 
20% Carbopol 974P-NF® had a much higher water 
uptake as expected due to its well documented 
swelling properties (16). In our study, equilibrium 
swelling occurred at 2 h, with a 580% increase after 
which an erosion phenomenon was observed. After 5 
h, most of the Carbopol 974P-NF® containing tablet 
had disintegrated into the surrounding aqueous 
medium. 
Both HPMC K4M and Carbopol 974P-NF® 
containing formulations demonstrated higher swelling 
property than CS-M, however in both cases, tablet 
disintegration and erosion was evident within 5 h. In 
comparison, CS-M had a relatively lower uptake of 
water but showed no signs of erosion even after the 5 
h study, maintaining consistency and rigidity of its 
shape and a swelling capacity of 300 times its original 
weight. It is postulated that the presence of sodium 
chloride crystals played an important role in the 
swelling rate of the polymers when compared to the 
other polymers in the study. The retention of shape 
could play an important role in the design of 
controlled release systems with predictable kinetics. 
The effect of water on the tablet formulation created 
microscopic pores as sodium chloride slowly 
dissolved in the surrounding medium. The creation of 
the pore effect in essence allowed the CS-M polymer 
to swell rapidly and reach equilibrium within the first 
hour. The results of the swelling study correlated well 
with in vitro dissolution data thereby confirming the 
release pattern of drug was proportional to the 
swelling capacity of the polymer. 
Figure 3. Polymer swelling (water uptake) capacity 
of 20% concentration of HPMC K4M (F1), 
Carbopol 974P-NF®(F2) and CS-M (F3) 
formulations (n=3). 
 
In vitro drug release studies 
Optimization studies were conducted to determine the 
ideal concentration range of CS-M to be used in tablet 
formulations. As observed in Figure 4, niacinamide 
drug release characteristics were evaluated at 20% 
concentrations of HPMC K4M (F1) and Carbopol 
974P-NF® (F2) and CS-M (F3). At 20% CS-M 
concentration, the sodium chloride present in CS-M 
seemingly controls the release of drug and increases 
the lag time of drug release. The amount of sodium 
chloride in the tablet causes a salting out effect in 
which the salt occupies the water molecules making 
the CS-M polymer less water soluble. Gonzalez-
Rodriguez et al., (17) demonstrated that formulations 
containing sodium chloride showed longer lag times 
due to the plastic deformation properties; when 
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compressed, sodium chloride leads to a less porous, 
more compact network which strictly controls solvent 
penetration, drug dissolution and release rate. Another 
study performed by Amiji (18) stated that sodium 
chloride at different concentrations was added to 
chitosan solutions (made with acetic acid and 
hydrochloric acid) to adjust the ionic strength, and 
since the interactions between chitosan chains occur 
primarily through the amine groups, increasing the 
ionic strength of the medium does enhance the 
hydrophobic association. Thus, the addition of sodium 
chloride reduces the amount of drug release. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
The in vitro drug release of niacinamide drug from 
20% CS-M was compared with similar concentrations 
of commercially available polymers Carbopol 974P- 
NF® and hydroxypropyl methylcellulose (HPMC 
K4M). As observed in Figure 4, the rate of drug 
release from Carbopol 974P-NF® (F1) and CS-M 
(F3) was consistent for the first 4 h of the run after 
which CS-M was observed to be more controlled than 
the Carbopol 974P-NF® containing formulation for 
the duration of the study (> 8 h).       
HPMC K4M formulation (F1) showed a consistent 
pattern of release over the duration of the study, 
however it was observed to release niacinamide at a 
faster rate than the other two polymer formulations. 
From the swelling capacity studies, the high water 
uptake of Carbopol 974P-NF® prolonged the release 
rate of the drug initially by creating a gel structure and 
extended channels that prevented the drug from 
diffusing out of the tablet quickly (19). However, the 
swelling effect diminished rapidly resulting in a faster 
release of the drug over the duration of the study. In 
case of the CS-M containing formulation, a gel 
transformation occurred which exhibited no 
disintegration and erosion, maintaining its shape for 
the duration of the study. This retention of shape 
ensured steady release of drug and hence prevented 
dose dumping (20). Overall, CS-M based 
formulations exhibited an ideal release profile when 
compared to the commercial brands, thus 
demonstrating comparable performance to these 
polymers.  
Prior to the in vitro dissolution studies, three tablets 
were taken from each formulation to verify content 
uniformity. The total drug content for these tablets 
averaged 97% + 7%.  
 
In vitro bioadhesion studies 
The bioadhesion analyses of all three formulations 
tested are shown on Figure 5. A number of polymeric 
characteristics are necessary for muco- or bio-
adhesion, which can be summarized as follows: (a) 
strong hydrogen bonding groups (-OH, -COOH)  (b) 
strong anionic charges (c) high molecular weight (d) 
sufficient chain flexibility (e) surface energy 
properties favoring spreading onto mucus (21). Figure 
5 represents the bioadhesion strength of the various 
polymers tested (in dynes/cm2). The strength to break 
the bond between the tissue and the swollen tablets 
(fracture theory) were between 31-35 dynes/cm2. 
HPMC K4M is a non-ionic polymer, therefore 
bioadhesion of this polymer to the tissue was probably 
due to hydrogen bonding.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 A comparative cumulative release (%) profile of 
niacinamide drug from 20% concentration of HPMC K4M 
(F1), Carbopol 974P-NF (F2) and CS-M hydrogel polymer 
(F3) based formulations (n=3). 
Figure 5 Bioadhesion strength (dynes/cm2) analysis of 
tablets containing 20% concentration of HPMC K4M (F1), 
Carbopol 974P-NF (F2) and CS-M (F3). 
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Bioadhesion of Carbopol 974P-NF®, an anionic 
polymer to the intestinal membrane seemed to be 
because of its partially ionizable carboxylic acid 
groups. The bioadhesion phenomena of Carbopol 
974P-NF® and the membrane tissue composed of two 
mechanisms, a chemical interaction between 
functional groups and an interpenetration of the 
polyacrylic acid chains into the mucus, which was 
favored by high swelling (12).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In case of the CS-M formulation, since the parent 
compound chitosan is a cationic polymer, bioadhesion 
of CS-M to the intestinal tissue was through the 
electrostatic interaction of the positively charged 
polymer with the negatively charged surface of the 
membrane. Lehr et al., (21), reported that positively 
charged polymeric hydrogels could possibly develop 
additional molecular attraction forces by electrostatic 
interactions with negatively charged mucosal 
surfaces. Overall, there was no evidence of the 
bioadhesive strengths of each of the polymer to be 
significantly different from each other, although CS-
M formulations did exhibit a higher bioadhesive force 
compared to the other polymers.  
 
Drug permeability studies 
The permeability of the niacinamide drug was 
evaluated using the everted sac intestinal tissue 
method (Figure 6).  The total amount of drug transport 
for the various formulations were as follows: CS-M > 
Carbopol 974P-NF > HPMC K4M . CS-M showed  
 
 
the highest amount of drug transported amongst all 
the formulations. Chitosan is a well known absorption 
enhancer and acts by opening the tight junctions in the 
epithelial cells of the everted sac thus permitting more 
drug to pass through (22). Because of their positive 
charge, chitosan can interact with anionic components 
of the glycoproteins on the surface of epithelial cells. 
It has also been suggested that cationic 
macromolecules are able to displace cations from 
electronegative sites (such as tight junctions) on a 
membrane which require coordination with cations 
with dimensional stability. In addition, it has been 
shown that the interior of the tight junction channels 
(pores) are highly hydrated and contain fixed negative 
charges. The relative concentration of specific type of 
ions within the pores could result in substantial 
alterations in tight junction resistance leading to 
loosening or opening of the pore. Another study 
confirming the nature of chitosan as an absorption 
enhancer was performed by Schipper et al., (23) 
where it was found that the positive charge of the 
chitosan polymer makes possible a charge interaction 
between the chitosan and the negatively charged 
surface of the epithelial cell membrane.  
Figure 6 Permeability studies using the intestinal everted 
sac method showing amount of drug transported from 
formulations containing 20% concentration of HPMC 
K4M (F1), Carbopol 974P-NF (F2) and CS-M (F3). 
 
 
Storage stability studies  
All tablet formulations (F1-F3) were subject to 
stability studies to evaluate the degradation of the 
tablet formulations after storage of 3 mo. Figure 7 
shows the drug release profiles after one, two and 
three months of storage (stored at 40°C/ 75% RH).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7 Cumulative niacinamide drug release from 
tablets containing 20% concentrations of HPMC K4M 
(F1), Carbopol 974P-NF (F2) and CS-M (F3).   
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As seen from Figure 7, after 3 mo. of storage there 
were no significant differences in release rates of 
niacinamide from any of the formulations. 
Formulation (F2) containing Carbopol 974P-NF® 
(F2)  showed a slight decrease in drug release after 3 
months of storage however the difference was 
insignificant compared to other polymers. CS-M 
formulation (F3) also demonstrated a stable profile 
indicating that no drug degradation was apparent. 
Overall, all polymer formulations appeared to be 
stable in terms of drug release for the duration of the 3 
mo study. 
 
Conclusion 
In conclusion, we successfully developed a novel 
chitosan hydrogel salt complex polymer using a 
freeze-drying method thus providing a good 
alternative to the use of parent chitosan with its 
inherent problems in formulation development. When 
compared to conventional polymers such as HPMC 
K4M and Carbopol 974P-NF ®, the modified 
chitosan compound demonstrated better 
characteristics in terms of swelling properties, in vitro 
drug release from the polymer and transport of drug 
across the intestine. In terms of bioadhesion and 
stability, the modified chitosan CS-M showed similar 
characteristics to its commercial counterparts. 
Overall, the modified chitosan polymer exhibited 
better qualities than its parent compound, chitosan, 
and thus may be of use to create controlled release 
formulations. 
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